Media Centre
Latest press releases
-
Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysis
-
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
-
Imfinzi approved in the US for less-frequent, fixed-dose use
-
AstraZeneca demonstrates strengths in haematology with robust data at ASH 2020
-
Update on CALAVI Phase II trials for Calquence in patients hospitalised with respiratory symptoms of COVID-19
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 203 749 5916
Rebecca Einhorn
Director Global Media Relations (Oncology)
+1 301 398 1802
Kim Blomley
Director Global Media Relations (Oncology)
+44 7385 367659
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 203 749 5906
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 122 334 4690
Jennifer Hursit
Manager Global Media Relations
+44 203 749 5762
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
